Tango Therapeutics, Inc. · NASDAQ:TNGX
Dapice Joshua J. reported a 9.99% stake in Tango Therapeutics, Inc. (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 6, 2026
Dapice Joshua J. reported a 9.99% stake in Tango Therapeutics, Inc., 13,461,215 shares, as a passive investor on Dec 31, 2025. Filed Feb 6, 2026 (Schedule 13G/A).
- Stake
- 9.99%
- Shares
- 13,461,215
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 31 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Farallon Capital Partners, L.P. | 1.60% | 2,199,950 |
| Farallon Capital Institutional Partners, L.P. | 2.20% | 2,922,242 |
| Farallon Capital Institutional Partners II, L.P. | 0.50% | 710,502 |
| Farallon Capital Institutional Partners III, L.P. | 0.40% | 496,032 |
| Four Crossings Institutional Partners V, L.P. | 0.40% | 605,612 |
| Farallon Capital Offshore Investors II, L.P. | 3.90% | 5,280,943 |
| Farallon Capital (AM) Investors, L.P. | 0.30% | 359,837 |
| Farallon Capital F5 Master I, L.P. | 0.40% | 556,097 |
| Farallon Healthcare Partners Master, L.P. | 0.20% | 330,000 |
| Farallon Partners, L.L.C. | 9.60% | 12,905,118 |
| Farallon Institutional (GP) V, L.L.C. | 0.40% | 605,612 |
| Farallon F5 (GP), L.L.C. | 0.40% | 556,097 |
| Farallon Healthcare Partners (GP), L.L.C. | 0.20% | 330,000 |
| Dapice Joshua J. | 9.99% | 13,461,215 |
| Dreyfuss, Philip D. | 9.99% | 13,461,215 |
| Dunn Hannah E. | 9.99% | 13,461,215 |
| Fried, Richard B | 0% | 0 |
| Gehani, Varun N. | 9.99% | 13,461,215 |
| Giauque, Nicolas | 9.99% | 13,461,215 |
| Husen, Avner A. | 9.99% | 13,461,215 |
| Kim, David T. | 9.99% | 13,461,215 |
| Linn, Michael G. | 9.99% | 13,461,215 |
| Luo Patrick (Cheng) | 9.99% | 13,461,215 |
| Patel, Rajiv A. | 0% | 0 |
| Roberts, Jr., Thomas G. | 9.99% | 13,461,215 |
| Saito Edric C. | 9.99% | 13,461,215 |
| Seybold, William | 0% | 0 |
| Short Daniel S. | 9.99% | 13,461,215 |
| Spokes, Andrew J. M. | 9.99% | 13,461,215 |
| Warren, John R. | 9.99% | 13,461,215 |
| Wehrly, Mark C. | 9.99% | 13,461,215 |